Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease

Bauersachs, 2010, Oral rivaroxaban for symptomatic venous thromboembolism, N Engl J Med, 363, 2499, 10.1056/NEJMoa1007903 Buller, 2012, Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, N Engl J Med, 366, 1287, 10.1056/NEJMoa1113572 Schulman, 2009, Dabigatran versus warfarin in the treatment of acute venous thromboembolism, N Engl J Med, 361, 2342, 10.1056/NEJMoa0906598 Agnelli, 2013, Oral Apixaban for the Treatment of Acute Venous Thromboembolism, N Engl J Med, 369, 799, 10.1056/NEJMoa1302507 Burnett, 2016, Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment, J Thromb Thrombolysis, 41, 206, 10.1007/s11239-015-1310-7 Schulman, 2015, Perioperative management of dabigatran: a Prospective Cohort Study, Circulation, 132, 167, 10.1161/CIRCULATIONAHA.115.015688 Schulman, 2010, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients, J Thromb Haemost, 8, 202, 10.1111/j.1538-7836.2009.03678.x Schulman, 2005, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients, J Thromb Haemost, 3, 692, 10.1111/j.1538-7836.2005.01204.x Sherwood, 2014, Circulation, 129, 1850, 10.1161/CIRCULATIONAHA.113.005754 Garcia, 2014, Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures, Blood, 124, 3692, 10.1182/blood-2014-08-595496 Clark, 2015, Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures, JAMA Intern Med, 175, 1163, 10.1001/jamainternmed.2015.1843 Douketis, 2015, Perioperative bridging anticoagulation in patients with atrial fibrillation, N Engl J Med, 373, 823, 10.1056/NEJMoa1501035 Siegal, 2012, Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta‐analysis of bleeding and thromboembolic rates, Circulation, 126, 1630, 10.1161/CIRCULATIONAHA.112.105221 Le Gal, 2009, Validation of a diagnostic approach to exclude recurrent venous thromboembolism, J Thromb Haemost, 7, 752, 10.1111/j.1538-7836.2009.03324.x Siragusa, 2008, Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Comparession Ultrasonography (DACUS) study, Blood, 112, 511, 10.1182/blood-2008-01-131656